S&P Healthcare 18,500.00 10.11%
  • Sun Pharmaceutical Industries Ltd. 0000.00
  • Divi’s Laboratories Ltd. 0000.00
  • Cipla Ltd. 0000.00
  • Torrent Pharmaceuticals Ltd. 0000.00
  • Dr. Reddy’s Laboratories Ltd. 0000.00
  • Zydus Lifesciences Ltd. 0000.00
  • Mankind Pharma Ltd. 0000.00
  • Lupin Ltd. 0000.00
  • Aurobindo Pharma Ltd. 0000.00
  • Alkem Laboratories Ltd. 0000.00
  • Glenmark Pharmaceuticals Ltd. 0000.00
  • Natco Pharma Ltd. 0000.00
  • Shilpa Medicare Ltd. 0000.00
  • Ajanta Pharma Ltd. 0000.00
  • J B Chemicals & Pharmaceuticals Ltd. 0000.00
  • Apollo Hospitals Enterprise Ltd. 0000.00
  • Fortis Healthcare Ltd. 0000.00
  • Max Healthcare Institute Ltd. 0000.00
  • Narayana Hrudayalaya Ltd. 0000.00
  • Shalby Ltd. 0000.00
  • Poly Medicure Ltd. 0000.00
  • Medi Assist India Ltd. 0000.00
  • ICICI Lombard General Insurance Company Ltd. 0000.00
  • HDFC Life Insurance Company Ltd. 0000.00
  • SBI Life Insurance Company Ltd. 0000.00
  • Bajaj Finserv Ltd. 0000.00
  • Metropolis Healthcare Ltd. 0000.00
  • Thyrocare Technologies Ltd. 0000.00

India-Jordan Strengthens Ties, Modi Encourages Health Tech, Digital Infra Boost

India-Jordan Strengthens Ties, Modi Encourages Health Tech, Digital Infra Boost

The visit, which also included talks on strengthening health-tech collaborations and boosting digital infrastructure, highlighted the potential for Indian firms to set up manufacturing units in Jordan.

Prime Minister Narendra Modi has recently urged Indian companies operating in Jordan to explore opportunities to establish manufacturing units for medicines and medical devices.

On his official visit to Jordan in December 2025, PM Modi emphasized the key role Indian pharmaceutical companies could play in enhancing the availability of affordable medicines and medical devices in the region.

The talks also focused on strengthening health tech collaborations, with an emphasis on boosting digital infrastructure in the region.

Modi emphasized the potential of this partnership to enhance the accessibility and affordability of healthcare solutions, both in Jordan and the broader Middle East, while fostering innovation in medical technology.

Highlighting Jordan’s strategic location and its access to regional markets, Modi emphasized the potential of such partnerships in driving healthcare innovation and supply chain development in the region.

The PM further added that leveraging Jordan's favorable trade environment and skilled workforce can lead to the development of critical healthcare products such as generic drugs, vaccines, and diagnostic devices.

During discussions with Jordanian leaders, Modi stated, “Our pharmaceutical companies can play a pivotal role in enhancing the availability of affordable medicines and medical devices in the region.”

The visit, which also included talks on strengthening health tech collaborations and boosting digital infrastructure, highlighted the potential for Indian firms to set up manufacturing units in Jordan.

Modi stressed that this collaboration would not only benefit Jordan’s healthcare infrastructure but also reinforce India’s position as a global hub for healthcare manufacturing.

Indian companies entering the Jordanian market through such ventures could also gain access to broader Middle Eastern and African markets, supporting Jordan’s aspirations to become a center for health technology innovation.

Narendra Modi also pointed out that these manufacturing ventures would bring new employment opportunities and facilitate the transfer of technology and expertise to Jordan, ultimately fostering innovation and improving the quality of healthcare delivery in both countries.

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All